Frequent reduction or loss of DCC gene expression in human osteosarcoma.

Por Horstmann, M. A., Pösl, M., Scholz, R. B., Anderegg, B., Simon, P., Baumgaertl, K., Delling, G., Kabisch, H.
Publicado em 1997

Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

Por van der Veer, A, van der Velden, V H J, Willemse, M E, Hoogeveen, P G, Petricoin, E F, Beverloo, H B, Escherich, G, Horstmann, M A, Pieters, R, den Boer, M L
Publicado em 2014

Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia

Por Vesely, C, Frech, C, Eckert, C, Cario, G, Mecklenbräuker, A, zur Stadt, U, Nebral, K, Kraler, F, Fischer, S, Attarbaschi, A, Schuster, M, Bock, C, Cavé, H, von Stackelberg, A, Schrappe, M, Horstmann, M A, Mann, G, Haas, O A, Panzer-Grümayer, R
Publicado no Leukemia (2017)

KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia

Por Malinowska-Ozdowy, K, Frech, C, Schönegger, A, Eckert, C, Cazzaniga, G, Stanulla, M, zur Stadt, U, Mecklenbräuker, A, Schuster, M, Kneidinger, D, von Stackelberg, A, Locatelli, F, Schrappe, M, Horstmann, M A, Attarbaschi, A, Bock, C, Mann, G, Haas, O A, Panzer-Grümayer, R
Publicado no Leukemia (2015)

RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia

Por Jerchel, I S, Hoogkamer, A Q, Ariës, I M, Steeghs, E M P, Boer, J M, Besselink, N J M, Boeree, A, van de Ven, C, de Groot-Kruseman, H A, de Haas, V, Horstmann, M A, Escherich, G, Zwaan, C M, Cuppen, E, Koudijs, M J, Pieters, R, den Boer, M L
Publicado no Leukemia (2018)